Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women
Figure 3. Prevalence of ctDNA oncogenic mutations in the (A) PI3K pathway and loss-of-function mutations in (B) DNA damage response and (C) tumor suppressor pathways. ctDNA, circulating tumor-derived DNA.